Skip to menu Skip to content Skip to footer

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING.

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

Gobe, G. C., Johnson, D. W., Li, J., Pat, B. K., Percy, C. J. and Rajandram, R. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

Liu, H., McTaggart S., Johnson, D. W. and Gobe, G. C. (2007). MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure. World Congress of Nephrology 2007 (WCN2007), Rio de Janeiro, Brazil, 21-25 April 2007. International Society of Nephrology.

MSC protect renal tubular epithelium from oxidative stress in vitro: support for a protective or regenerative role in acute renal failure

2007

Conference Publication

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

Yamada, M., Burke, C., Colditz, P., Johnson, D. W. and Gobe, G. C. (2007). Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury. Australian Society of Medical Research Annual Scientific Meeting, Blue Mountains, NSW, November, 2007.

Vascular and structural cell response to erythropoietin in the neonatal brain during hypoxic injury

2007

Conference Publication

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The effect of diabetes mellitus on access related infection in both peritoneal dialysis and haemodialysis patients

2007

Conference Publication

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

Ghali, J., McDonald, S., Bannister, K. M., ANZDATA Peritonitis Working Group and Johnson, D. W. (2007). Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes. Nephrology 2007: 43rd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Gold Coast, QLD, Australia, 8-12 September 2007. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2007.00847.x

Peritonitis in Australian peritoneal dialysis patients: Microbiology, treatment and outcomes

2007

Conference Publication

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

Staatz, Christine, Wong, Jenny, Taylor, Paul, Johnson, David and Tett, Susan (2007). Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period. 10th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, Nice, France, 9-14 September, 2007. New York: Lippincott-Raven. doi: 10.1097/FTD.0b013e31813797e8

Mycophenolic acid AUC on day 5 post-renal transplant and related outcomes in the early post-operative period

2007

Conference Publication

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers. National Cancer Research Institute Conference, Birmingham, England, 2-5 October, 2007.

TRAFs, CARDs and CIDEs are novel apoptotic gene families in therapy-treated renal cell carcinoma and potential diagnostic markers

2007

Conference Publication

The prevalence of obesity in CKD

Frazier, J., Johnson, D., Hawley, C., Campbell, S., Mudge, D., Van Eps, C., Isbel, N. and Leslie, J. (2007). The prevalence of obesity in CKD. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The prevalence of obesity in CKD

2007

Conference Publication

Adverse outcomes in alternate nightly home nocturnal haemodialysis

van Eps, Carolyn, Jeffries, Janine, Isbel, Nicole, Johnson, David, Campbell, Scott, Mudge, David and Hawley, Carmel (2007). Adverse outcomes in alternate nightly home nocturnal haemodialysis. 44th ERA-EDTA Congress, Barcelona, Spain, 22-24 June 2007 . Oxford, United Kingdom: Oxford University Press.

Adverse outcomes in alternate nightly home nocturnal haemodialysis

2007

Conference Publication

Molecular and cellular changes associated with age-related chronic kidney disease

Percy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007.

Molecular and cellular changes associated with age-related chronic kidney disease

2007

Conference Publication

Erythropoietin: Novel applications beyond anaemia treatment

Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.

Erythropoietin: Novel applications beyond anaemia treatment

2007

Conference Publication

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD). 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

2007

Conference Publication

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers. 46th ASMR National Scientific Conference, Katoomba, N.S.W., Australia, 11-13 November 2007.

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

2007

Conference Publication

What is the optimal fat mass in peritoneal dialysis patients?

Johnson, David W. (2007). What is the optimal fat mass in peritoneal dialysis patients?. 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25 - 29 August, 2006. Milton, Ontario: Multimed.

What is the optimal fat mass in peritoneal dialysis patients?

2007

Conference Publication

Live donor characteristics over the last 15 years

Kaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Live donor characteristics over the last 15 years

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. American Transplant Congress, San Francisco, CA, USA, 5-9 May 2007. Oxford, England: Wiley-Blackwell. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

Kaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient